The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Refining neutropenia risk assessment in patients treated with first-line endocrine therapy (ET) and cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) for metastatic breast cancer (MBC) through a cell-free DNA workflow (cfDNA).
 
lorenza Palmero
No Relationships to Disclose
 
Roberta Mazzeo
No Relationships to Disclose
 
Silvia Buriolla
No Relationships to Disclose
 
Lorenzo Allegri
No Relationships to Disclose
 
Lucia Bortot
No Relationships to Disclose
 
Alessandra Franzoni
Consulting or Advisory Role - Lilly (I); Novartis (I)
 
Anna Michelotti
No Relationships to Disclose
 
Elisabetta Camilla Stefani
No Relationships to Disclose
 
Giulia Turra
No Relationships to Disclose
 
Miriam Zilli
No Relationships to Disclose
 
Paola Di Nardo
No Relationships to Disclose
 
Rossana Roncato
No Relationships to Disclose
 
Marta Bonotto
No Relationships to Disclose
 
Erika Cecchin
No Relationships to Disclose
 
Barbara Belletti
No Relationships to Disclose
 
Giuseppe Toffoli
No Relationships to Disclose
 
Lorenzo Gerratana
Consulting or Advisory Role - Lilly; Novartis
Travel, Accommodations, Expenses - Menarini Silicon Biosystems
 
Gustavo Baldassarre
Travel, Accommodations, Expenses - ZEISS
 
Giuseppe Damante
No Relationships to Disclose
 
Fabio Puglisi
Honoraria - AstraZeneca; Daiichi Sankyo; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; Eisai; Lilly; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Eisai; Roche
Travel, Accommodations, Expenses - Celgene; Roche